Showing results (1-10 of 303) with videos related to
Sort By:
Pageof 31
European Clinical Respiratory Journal|October 31, 2025
Nordic Respiratory Academy: a historical note and reflectionAmund Gulsvik, Per Sigvald Bakke, Knut StavemRespiratory Medicine|December 26, 2006
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult communitySverre Lehmann, Per Sigvald Bakke, Geir Egil Eide, et al.Plos One|October 20, 2022
Respiratory symptoms and cardiovascular causes of deaths: A population-based study with 45 years of follow-upKnut Stavem, Henrik Schirmer, Amund GulsvikPulmonary Pharmacology & Therapeutics|September 20, 2005
Bronchodilator reversibility testing in an adult general population; the importance of smoking and anthropometrical variables on the response to a beta2-agonistSverre Lehmann, Per Sigvald Bakke, Geir Egil Eide, et al.Plos One|November 22, 2021
Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation timeKnut Stavem, Ane Johannessen, Rune Nielsen, et al.Respiratory Medicine|May 18, 2013
Increased prevalence of chronic obstructive pulmonary disease in a general populationMarie Waatevik, Trude Duelien Skorge, Ernst Omenaas, et al.Respiratory Medicine|October 30, 2010
Excessive costs of COPD in ever-smokers. A longitudinal community studyRune Nielsen, Ane Johannessen, Ernst Reidar Omenaas, et al.The Clinical Respiratory Journal|March 20, 2010
Aspects of healthcare utilisation in self-reported obstructive lung diseaseRune Nielsen, Ane Johannessen, Per Sigvald Bakke, et al.The Clinical Respiratory Journal|June 23, 2010
Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results?Inga-Cecilie Sørheim, Ane Johannessen, Thomas Blix Grydeland, et al.ERJ Open Research|January 19, 2023
Period and cohort effects: consequences on spirometric lung function in Norway during the 20th centuryLucia Cestelli, Ane Johannessen, Knut Stavem, et al.Pageof 31